Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial.
von Minckwitz G, Loibl S, Brunnert K, Kreienberg R, Melchert F, Mösch R, Neises M, Schermann J, Seufert R, Stiglmayer R, Stosiek U, Kaufmann M. von Minckwitz G, et al. Among authors: kaufmann m. Eur J Cancer. 2002 Nov;38(17):2265-71. doi: 10.1016/s0959-8049(02)00378-7. Eur J Cancer. 2002. PMID: 12441263 Clinical Trial.
A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93.
Kaufmann M, Graf E, Jonat W, Eiermann W, Vescia S, Geberth M, Conrad B, Gademann G, Albert US, Loibl S, von Minckwitz G, Schumacher M; German Adjuvant Breast Cancer Study Group (GABG). Kaufmann M, et al. Eur J Cancer. 2007 Nov;43(16):2351-8. doi: 10.1016/j.ejca.2007.08.012. Epub 2007 Sep 25. Eur J Cancer. 2007. PMID: 17897821 Clinical Trial.
New endocrine approaches in the treatment of breast cancer.
von Minckwitz G, Kaufmann M. von Minckwitz G, et al. Among authors: kaufmann m. Biomed Pharmacother. 1998;52(3):122-32. doi: 10.1016/S0753-3322(98)80090-5. Biomed Pharmacother. 1998. PMID: 9755805 Review.
Use of goserelin in the treatment of breast cancer.
Rody A, Loibl S, von Minckwitz G, Kaufmann M. Rody A, et al. Among authors: kaufmann m. Expert Rev Anticancer Ther. 2005 Aug;5(4):591-604. doi: 10.1586/14737140.5.4.591. Expert Rev Anticancer Ther. 2005. PMID: 16111461 Review.
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).
von Minckwitz G, Graf E, Geberth M, Eiermann W, Jonat W, Conrad B, Brunnert K, Gerber B, Vescia S, Wollert J, Kaufmann M. von Minckwitz G, et al. Among authors: kaufmann m. Eur J Cancer. 2006 Aug;42(12):1780-8. doi: 10.1016/j.ejca.2006.04.006. Epub 2006 Jun 12. Eur J Cancer. 2006. PMID: 16765589 Clinical Trial.
1,399 results